02-04-2021 02:17 PM | Source: Religare Broking Ltd
Dabur India Ltd - Stellar performance, ayurvedic and health portfolio to drive growth By Religare Broking
Dabur India Ltd.
Outlook & Valuation
Dabur’s portfolio is gaining traction each passing quarter largely driven by its focus on health and hygiene segment, new product launches, heavy investment behind their power brands and expanding in rural area. In addition cost optimisation measures and improving go-to-market approach is well supporting company’s growth. We remain positive on the company’s long term growth plans and have maintained a Buy on the stock with a target price of Rs 616.
To Read Complete Report & Disclaimer Click Here
Please refer disclaimer http://ex.religareonline.com/disclaimer
SEBI Registration number is INZ000174330
Above views are of the author and not of the website kindly read disclaimer
Latest News
Insurance Sector Update : Motor drags down overall g...
Sell Gold Below 72700 SL Above 72950 TGT 72400/72100...
Wipro shares nosedived over 9 pc after missed earnin...
Economic Survey links mental health disorders with '...
India's GDP growth for FY25 to surpass Economic Surv...
Evening Roundup : A Daily Report on Bullion Energy &...
FIIs stood as net buyers in equities as per July 22 ...
Union Budget: Experts urge government to remove 18 ...
Poonawalla Fincorp AUM up 52% YoY to Rs 26,972 crore...
Sensex ends lower ahead of Union Budget 2024-25